Kingfisher Healthcare Wins Clearance to Market KFH Energy in US
Posted on: Monday, 31 March 2008, 09:01 CDT
Kingfisher Healthcare has announced that the FDA has granted the company 510(k) clearance to market KFH Energy in the US.
The patented, high-tech medical device is said to alleviate fatigue and pain and has received the CE mark in Europe earlier.
KFH Energy utilizes a unique form of micro current electrotherapy called Bio-Electric Stimulation Therapy to enhance the body's physiological processes. Intended for home use, KFH Energy encapsulates this novel technology in a hand-held device. Its sleek and modern design elements, including the patented touch-screen panel, make the device both convenient and easy to use.
Henk Snyman, CEO of Kingfisher Healthcare (KFH), said: "We are thrilled to introduce KFH Energy to physicians, specialists, and patients throughout the US. With the proven success of KFH Energy, we anticipate that this technology will be the first in a suite of natural energy devices for a variety of treatments."
Source: Datamonitor
Related Articles
- Nomir Medical Presents Positive Onychomycosis Data for Its Noveon(R) Dual Wavelength Device
- Nomir Medical to Present Positive Onychomycosis Data for Its Noveon(R) Dual Wavelength Device
- Iberdrola and Tecnalia to Develop Wave Energy Project in Basque Country
- Tendril Electrical Outlet Certified ZigBee Smart
- Nomir Medical Initiates Pivotal Trial of Its Noveon(R) Dual Wave Length Device for the Treatment of Onychomycosis
- Sony Recalls Computer Batteries
- Gateway Announces Voluntary Battery Exchange Program
- Lenovo Rcalls168,500 Sony Laptop Batteries
- EnterSys Buys Majority Stake in Modular Energy
 |
 |
User Comments (0)
RSS Feeds